SelectQuote (SLQT) Q1 2027 earnings review
SelectQuote cuts its seasonal loss, but preferred costs erase gains
SelectQuote, the insurance broker and mail-order pharmacy, shrank its sales force to cut seasonal losses while its preferred stock charges kept growing. Revenue fell 15% from a year ago as Medicare policy volume and drug prices dropped, but lower marketing spend narrowed the operating loss in its slowest quarter. Chief executive Tim Danker kept the full-year outlook unchanged, which by our math leaves revenue down about 13% for the rest of the year.
| Revenue | $280.0M -14.8% from a year ago |
|---|---|
| Adjusted EBITDA | -$17.0M -$32.1M a year ago |
| Loss to common shareholders | -$40.5M after $20.2M of preferred stock charges |
| Full-year outlook | Unchanged middle of the range: -13.5% revenue, $102.5M Adjusted EBITDA |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because lower seasonal losses in the quietest quarter do not test the full-year plan, and financing costs still eat up the gains. Pharmacy profits rose and seasonal cash burn slowed, but compounding preferred stock charges of $20 million pushed common shareholders deeper into the red. One caution: the pharmacy margin merely matched last quarter's level while its customer count fell.
The question now is whether the planned doubling of operating cash flow comes from lasting efficiency at the Kansas pharmacy or just from releasing working capital as policy sales shrink. If Kansas automation drives it, pharmacy profit margins will climb above 6% as orders migrate; if shrinkage drives it, cash flow will stall once policy volume stabilizes. Second-quarter Medicare enrollment and pharmacy margins will tell.
🐂 Bull Case
Pharmacy Profit Rose Even as Membership Shrank
Healthcare Services, the division that runs the SelectRx mail-order pharmacy, is supposed to drive profit margins higher through a new facility in Olathe, Kansas. In the first quarter, the division's revenue fell 16% from a year ago to $186.3 million because the Inflation Reduction Act lowered drug prices. Even so, segment Adjusted EBITDA — earnings before interest, taxes, depreciation, amortization, and one-offs — jumped 56% to $11.2 million.
SelectQuote said its new "Pharmacy Management System is live and shipping prescriptions" in Kansas, and it pointed to "PBM stability maintained through multi-year contract" with pharmacy benefit managers, the middlemen that set drug payment rates. At the same time, active SelectRx members dropped 7% from a year ago to 99,753 (down 9,286 from last quarter) because management "refined customer qualification with a focus on long-term profitability and operational efficiency".
What to watch: the share of prescriptions shipped from Olathe in the second quarter. The division's 6% margin merely matches the fourth quarter's level and compares against a depressed year-ago period, so only a disclosed jump in Kansas volume will prove that automation, rather than easier comparisons, is lifting profit.
Smaller Agent Force Cut Losses Before Peak Selling
The first quarter is historically a money-losing preparation period ahead of Medicare's fall enrollment window. This year, chief executive Tim Danker said the insurance broker "strategically lowered agent headcount for Senior" and used voice artificial intelligence to screen over 200,000 calls and cut pharmacy enrollment call times by about 20%.
Because the US group hired fewer agents and automated screening, marketing and advertising expense fell from 18.8% of revenue a year ago to 16.6% by our math. That 2.3 percentage point reduction helped cut the company's consolidated Adjusted EBITDA loss almost in half, from $32.1 million a year ago to $17.0 million, even though total revenue dropped 15%.
What to watch: whether management confirms in the second quarter that its $30 million annual cost-savings program is fully in place. Achieving that target during peak Medicare selling will show the smaller agent force can handle high call volumes without sacrificing profit margins.
Seasonal Cash Burn Slowed Because Receivables Grew Less
SelectQuote has made operating cash flow its main financial target, planning for more than $60 million this fiscal year after generating $31.9 million last year. In the first quarter, cash used in operations improved by $4.4 million from a year ago to a $17.2 million outflow.
The cash burn shrank primarily because the broker wrote fewer insurance policies. When an agent sells a policy, the company books estimated multi-year commissions upfront as an asset called commissions receivable, which consumes working capital until insurers pay the cash over time. That receivable build slowed to $15.8 million this quarter from $29.0 million a year ago, offsetting a $10.9 million cash drain from paying down accounts payable.
What to watch: operating cash flow across the second and third quarters, which must top $77.2 million in the rest of the year by our math to meet the full-year plan. Generating that cash while paying suppliers on normal terms will prove the business can fund itself through shrinking policy volume.
🐻 Bear Case
Preferred Stock Costs Wipe Out Operating Gains
Danker said the insurance group is positioned to drive profit and cash flow for shareholders, and total net loss before preferred charges narrowed by $10.2 million from a year ago to $20.3 million. However, that operating progress is not reaching common shareholders because heavy financing costs sit ahead of them.
- Preferred dividends and accretion: $20.2 million in the first quarter, up from $17.5 million a year ago
- Preferred liquidation preference: $438.6 million, up $15.4 million in a single quarter by our math
- Total debt: $385.8 million, up $15.7 million from June as the company drew $21.0 million net on its credit line
- Cash and restricted cash on the balance sheet: $13.4 million, down from $20.7 million in June
Because the preferred stock compounds when dividends are not paid in cash, it added $20.2 million to the loss attributable to common shareholders, bringing their total quarterly loss to $40.5 million. Every dollar of operating improvement in the first quarter was absorbed by the growing claim of preferred holders and lenders.
What to watch: whether SelectQuote begins paying preferred dividends in cash after December 2026. Switching to cash payments would stop the preferred balance from compounding, but it would drain the operating cash flow management is counting on.
Medicare Advantage Policies Keep Falling
SelectQuote's Senior division sells private Medicare Advantage health plans to retirees on behalf of insurance companies. For four straight years, insurers have cut plan benefits and terminated unprofitable plans to repair their own margins. While Danker pointed to "an improving Medicare Advantage environment which we believe is on the horizon", first-quarter volume kept shrinking.
Approved Medicare Advantage policies dropped 18% from a year ago to 50,976, a steeper drop than the 10% to 15% full-year decline management previously planned for, even though the year-ago quarter had already fallen 32%. Higher commission rates lifted the estimated lifetime value of each policy by 16% to $890, but Senior revenue still fell 14% to $50.8 million.
What to watch: approved Medicare Advantage policies in the second quarter, which covers the fall annual enrollment period when the vast majority of seniors pick their plans. A drop worse than 15% from last year's 257,279 policies would threaten the Senior division's 20% profit margin floor.
Risks this quarter didn't answer
Four standing legal, listing, and operational concerns received no new data in the first-quarter earnings release or presentation.
- Department of Justice lawsuit: the False Claims Act action survived dismissal in March 2026; the quarterly filing's legal footnote will show if any settlement accrual has been recorded.
- Stock exchange listing compliance: boilerplate risk factors still cite compliance with New York Stock Exchange standards; the quarterly filing will show any notice or cure plan.
- Insurance carrier concentration: one major insurer previously accounted for 39% of revenue; the quarterly filing's revenue footnote will disclose current concentration.
- Kansas pharmacy volume share: management said the Olathe system is live, but only a disclosed percentage of total prescriptions shipped from the site during the second-quarter call will confirm the migration.
💲 Other KPIs
Total commissions receivable — future renewal commissions booked upfront when a policy is sold — rose 2.8% from a year ago and $15.8 million from June by our math. Growth has slowed from 4.3% at year-end as the broker sells fewer policies, which reduces the working capital tied up in new receivables.
Life insurance revenue fell 8.2% from a year ago after staying nearly flat in the fourth quarter. The company cited "a decrease in Final Expense agent head count", which drove final expense premiums down 32% to $20.1 million, though lower costs lifted the segment's Adjusted EBITDA 31% to $7.3 million.
Weighted-average diluted common shares rose 3.0% from a year ago, continuing a steady climb from 170.4 million two years ago. SelectQuote does not buy back stock, so employee equity awards and penny warrants steadily dilute common shareholders alongside the preferred stock accretion.
🔮 Guidance
Unchanged. The full-year plan still calls for revenue to fall 13.5% at the middle of the range from last year's $1.62 billion. By our math, that leaves $1.12 billion for the rest of the year, a 13.2% drop from a year ago, as lower drug prices under the Inflation Reduction Act and a smaller Medicare agent force weigh on sales.
Unchanged. At the middle of the range, the outlook has earnings before interest, taxes, depreciation, amortization, and one-offs falling 6.1% from last year's $109.1 million, while the margin expands to 7.3% from 6.7% by our math. After the first-quarter seasonal loss, the plan leaves $119.5 million (a 10.7% margin) for the rest of the year.
Unchanged. The outlook still calls for operating cash flow to nearly double from last year's $31.9 million (+88.2% at the $60 million floor by our math). Following the $17.2 million first-quarter outflow, the business must generate at least $77.2 million of operating cash across the remaining three quarters.
❓ Key Questions
Why did the release omit the free cash flow target?
Last quarter management planned for around $50 million of full-year free cash flow, which implied about $10 million of capital spending against the $60 million operating cash flow floor. First-quarter capital spending was $3.6 million, and the release did not mention free cash flow.
What share of prescriptions now ships from Olathe, Kansas?
The presentation says the Kansas pharmacy system is live and shipping prescriptions, but gives no volume figure. Investors need the percentage of orders routed through Olathe after fall enrollment to judge how much cost savings remain.
How large was last year's one-time supplier payment benefit?
Last year's annual report noted a one-time cash boost from moving the main pharmacy supplier to 30-day payment terms. In the first quarter, accounts payable and accrued expenses drained $10.9 million in cash versus an $11.4 million inflow a year ago.
When will preferred stock dividends switch to cash payments?
Unpaid dividends and accretion on the preferred stock added $15.4 million to its liquidation preference this quarter, reaching $438.6 million. Management has not said whether it will start paying cash dividends to stop that balance from compounding.